Myospryn: A multifunctional desmin-associated protein

Histochemistry and Cell Biology

Volumn 140, Issue 1, 2013, Pages 55-63

  Tsoupri, Elsa ^a   Capetanaki, Yassemi ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

AKAPs; Intermediate filaments; Lysosomes; Trafficking

Indexed keywords

CALCINEURIN; CONNECTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; DESMIN; MYOSPRYN; UNCLASSIFIED DRUG; CMYA5 PROTEIN, HUMAN; MUSCLE PROTEIN;

CELL ORGANELLE; ENZYME ACTIVITY; HUMAN; LYSOSOME; MUSCLE DISEASE; MYOCARDIAL DISEASE; MYOPATHY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SKELETAL MUSCLE; HEART DISEASE; HEART MUSCLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

MAMMALIA;

DESMIN; HEART DISEASES; HUMANS; MUSCLE PROTEINS; MYOCARDIUM;

EID: 84879799445     PISSN: 09486143     EISSN: 1432119X     Source Type: Journal    
DOI: 10.1007/s00418-013-1103-z     Document Type: Review

References (66)

1. Allen RE, Rankin LL, Greene EA, Boxhorn LK, Johnson SE, Taylor RG, Pierce PR (1991) Desmin is present in proliferating rat muscle satellite cells but not in bovine muscle satellite cells. J Cell Physiol 149:525-535
2. Bandyopadhyay U, Sridhar S, Kaushik S, Kiffin R, Cuervo AM (2010) Identification of regulators of chaperone-mediated autophagy. Mol Cell 39:535-547
3. Bassel-Duby R, Olson EN (2003) Role of calcineurin in striated muscle: development, adaptation, and disease. Biochem Biophys Res Commun 311:1133-1141
4. Benson MA, Newey SE, Martin-Rendon E, Hawkes R, Blake DJ (2001) Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 276:24232-24241
5. Benson MA, Tinsley CL, Blake DJ (2004) Myospryn is a novel binding partner for dysbindin in muscle. J Biol Chem 279:10450-10458
6. Capetanaki Y (2000) Desmin cytoskeleton in healthy and failing heart. Heart Fail Rev 5:203-220
7. Capetanaki Y (2002) Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function. Trends Cardiovasc Med 12(8):339-348
8. Capetanaki Y, Milner DJ, Weitzer G (1997) Desmin in muscle formation and maintenance: knockouts and consequences. Cell Struct Funct 22:103-116
9. Capetanaki Y, Bloch RJ, Kouloumenta A, Mavroidis M, Psarras S (2007) Muscle intermediate filaments and their links to membranes and membranous organelles. Exp Cell Res 313:2063-2076
10. Capitani M, Sallese M (2009) The KDEL receptor: new functions for an old protein. FEBS Lett 583:3863-3871
11. Chang L, Barlan K, Chou YH, Grin B, Lakonishok M, Serpinskaya AS, Shumaker DK, Herrmann H, Gelfand VI, Goldman RD (2009) The dynamic properties of intermediate filaments during organelle transport. J Cell Sci 122(16):2914-2923
12. Chen XW, Feng YQ, Hao CJ, Guo XL, He X, Zhou ZY, Guo N, Huang HP, Xiong W, Zheng H, Zuo PL, Zhang CX, Li W, Zhou Z (2008) DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release. J Cell Biol 181(5):201-791
13. Chen X, Lee G, Maher BS, Fanous AH et al (2010) GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol Psychiatry 16(11):1117-1129
14. Conover G, Gregorio CC (2011) The desmin coil 1B mutation K190A impairs nebulin Z-disc assembly and stabilizes actin thin filaments. J Cell Sci 124(20):3464-3476
15. Durham JT, Brand OM, Arnold M, Reynolds JG, Muthukumar L, Weiler H, Richardson JA, Naya FJ (2006) Myospryn is a direct transcriptional target for MEF2A that encodes a striated muscle, a-actinin-interacting, costamere-localized protein. J Biol Chem 281(10):6841-6849
16. Eriksson JE, He T, Trejo-Skalli AV, Härmälä-Braskén AS, Hellman J, Chou YH, Goldman RD (2004) Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments. J Cell Sci 117:919-932
17. Fruman DA, Pai SY, Klee CB, Burakoff SJ, Bierer BE (1996) Measurement of calcineurin phosphatase activity in cell extracts. Methods 9:146-154
18. Gard DL, Lazarides E (1982) Cyclic AMP-modulated phosphorylation of intermediate filament proteins in cultured avian myogenic cells. Mol Cell Biol 2(9):1104-1114
19. Goldfarb LG, Vicart P, Goebel HH, Dalakas MC (2004) Desmin myopathy. Brain 127:723-734
20. Hackman P, Vihola A, Haravuori H, Marchand S, Sarparanta J, De Seze J, Labeit S, Witt C, Peltonen L, Richard I, Udd B (2002) Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet 71:492-500
21. Höllrigl A, Puz S, Al-Dubai H, Kim JU, Capetanaki Y, Weitzer G (2002) Amino-terminally truncated desmin rescues fusion of des (-/-) myoblasts but negatively affects cardiomyogenesis and smooth muscle development. FEBS Lett 523:229-233
22. Höllrigl A, Hofner M, Stary M, Weitzer G (2007) Differentiation of cardiomyocytes requires functional serine residues within the amino-terminal domain of desmin. Differentiation 75:616-626
23. Kaufman SJ, Foster RF (1988) Replicating myoblasts express a muscle-specific phenotype. Pro Natl Acad Sci USA 85:9606-9610
24. Kielbasa OM, Reynolds JG, Wu CL, Snyder CM, Cho MY, Weiler H, Kandarian S, Naya FJ (2011) Myospryn is a calcineurin-interacting protein that negatively modulates slow-fiber-type transformation and skeletal muscle regeneration. FASEB J 25(7):2276-2286
25. Kouloumenta A, Capetanaki Y (2008) Study of the role of desmin IFs in the mechanisms of cell death in cardiomyopathies: desmin protein interactions, PhD thesis
26. Kouloumenta A, Mavroidis M, Capetanaki Y (2007) Proper perinuclear localizing of the TRIM-like protein myospryn requires its binding partner desmin. J Biol Chem 282(48):35211-35221
27. Kuisk IR, Li H, Tran D, Capetanaki Y (1996) A single MEF2 site governs desmin transcription in both heart and skeletal muscle during mouse embryogenesis. Dev Biol 174:1-13
28. Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, Rostkova E, Kristensen J, Brandmeier B, Franzen G, Hedberg B, Gunnarsson LG, Hughes SM, Marchand S, Sejersen T, Richard I, Edström L, Ehler E, Udd B, Gautel M (2005) The kinase domain of titin controls muscle gene expression and protein turnover. Science 308:1599-1603
29. Lazarides E (1980) Intermediate filaments as mechanical integrators of cellular space. Nature 283:249-256
30. Lazarides E, Capetanaki Y (1986) The striated muscle cytoskeleton: expression and assembly in development. ICN-UCLA Symposia in molecular biology of muscle development, pp 749-772
31. Li H, Choudhary SK, Milner DJ, Munir MI, Kuisk IR, Capetanaki Y (1994) Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators MyoD and myogenin. J Cell Biol 124:827-841
32. Li Z, Colucci-Guyon E, Pinçon-Raymond M, Mericskay M, Pournin S, Paulin D, Babinet C (1996) Cardiovascular lesions and skeletal myopathy in mice lacking desmin. Dev Biol 175:362-366
33. Li W, Zhang Q, Oiso N, Novak EK, Gautam R, O'Brien EP, Tinsley CL, Blake DJ, Spritz RA, Copeland NG, Jenkins NA, Amato D, Roe BA, Starcevic M, Dell'Angelica EC, Elliott RW, Mishra V, Kingsmore SF, Paylor RE, Swank RT (2003) Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat Genet 35:84-89
34. Lin X, Tombler E, Nelson PJ, Ross M, Gelman IH (1996) A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture. J Biol Chem 271(45):28430-28438
35. Mavroidis M, Capetanaki Y (2002) Extensive induction of important mediators of fibrosis and dystrophic calcification in desmin-deficient cardiomyopathy. Am J Pathol 160:943-952
36. Milner DJ, Weitzer G, Tran D, Bradley A, Capetanaki Y (1996) Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol 134:1255-1270
37. Milner DJ, Taffet GE, Wang X, Pham T, Tamura T, Hartley C, Gerdes AM, Capetanaki Y (1999) The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function. J Mol Cell Cardiol 31:2063-2076
38. Milner DJ, Mavroidis M, Weisleder N, Capetanaki Y (2000) Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J Cell Biol 150:1283-1297
39. Nakagami H, Kikuchi Y, Katsuya T, Morishita R, Akasaka H, Saitoh S, Rakugi H, Kaneda Y, Shimamoto K, Ogihara T (2007) Gene polymorphism of myospryn (Cardiomyopathy-Associated 5) is associated with left ventricular wall thickness in patients with hypertension. Hypertens Res 30(12):1239-1246
40. Nauert JB, Klauck TM, Langeberg LK, Scott JD (1997) Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein. Curr Biol 7(1):52-62
41. Nikouli S, Capetanaki Y (2012) Isolation and characterization of cardiac side population (SP) stem cells of adult wt and des (-/-) mice, MSci thesis
42. Panagopoulou P, Davos CH, Milner DJ, Varela E, Cameron J, Mann DL, Capetanaki Y (2008) Desmin mediates TNF-a induced aggregate formation and intercalated disk reorganization in heart failure. J Cell Biol 181(5):761-775
43. Pfister O, Mouquet F, Jain M, Summer R, Helmes M, Fine A, Colucci WS, Liao R (2005) CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 97:52-61
44. Psarras S, Mavroidis M, Sanoudou D, Davos C, Xanthou G, Varela E, Panoutsakopoulou V, Capetanaki Y (2012) Regulation of adverse remodeling by osteopontin in a genetic heart failure model. Eur Heart J 33:1954-1963
45. Rapti K, Capetanaki Y (2007) Desmin deficient Cardiomyopathy is ameliorated by overexpression of antioxidant enzymes MnSOD and catalase. J Mol Cellul Cardiol 42:S162
46. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S, Guffanti A, Minucci S, Pelicci PG, Ballabio A (2001) The tripartite motif family identidies cell compartments. EMBO J 20(9):2140-2151
47. Reynolds JG, McCalmon SA, Tomczyk T, Naya FJ (2007) Identification and mapping of protein kinase A binding sites in the costameric protein myospryn. Biochim Biophys Acta 1173:891-902
48. Reynolds JG, McCalmon SA, Donaghey JA, Naya FJ (2008) Deregulated protein kinase A signaling and myospryn expression in Muscular dystrophy. J Biol Chem 283(13):8070-8074
49. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier L, Devaud C, Pasturaud P, Roudaut C et al (1995) Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81:27-40
50. Ruehr ML, Russell MA, Bond M (2004) A-kinase anchoring protein targeting of protein kinase A in the heart. J Mol Cell Cardiol 37:653-665
51. Russell MA, Lund LM, Haber R, McKeegan K, Cianciola N, Bond M (2006) The intermediate filament protein, synemin, is an AKAP in the heart. Arch Biochem Biophys 456(2):204-215
52. Salazar G, Craige B, Styers ML, Newell-Litwa KA, Doucette MM, Wainer BH, Falcon-Perez JM, Dell'Angelica EC, Peden AA, Werner E, Faundez V (2006) BLOC-1 complex deficiency alters the targeting of adaptor protein complex-3 cargoes. Mol Biol Cell 17:4014-4026
53. Sarparanta J, Blandin G, Charton K, Vihola A, Marchand S, Milic A, Hackman P, Ehler E, Richard I, Udd B (2010) Interactions with M-band titin and calpain 3 link myospryn (CMYA5) to Tibial and Limb-girdle muscular Dystrophies. J Biol Chem 285(39):30304-30315
54. Senter L, Ceoldo S, Petrusa MM, Salviati G (1995) Phosphorylation of dystrophin: effects on actin binding. Biochem Biophys Res Commun 206:57-63
55. Starcevic M, Dell'Angelica EC (2004) Identification of snapin and three novel proteins (BLOS1, BLOS2, and BLOS3/reduced pigmentation) as subunits of biogenesis of lysosome-related organelles complex-1 (BLOC-1). J Biol Chem 279:28393-28401
56. Styers ML, Salazar G, Love R, Peden AA, Kowalczyk AP, Faundez V (2004) The endosomal sorting machinery interacts with the intermediate filament cytoskeleton. Mol Biol Cell 15:5369-5382
57. Tkatchenko AV, Piétu G, Cros N, Gannoun-Zaki L, Auffray C, Léger JJ, Dechesne CA (2001) Identification of altered gene expression in skeletal muscles from Duchenne muscular dystrophy patients. Neuromuscul Disord 11:269-277
58. Trockenbacher A, Suckow V, Foerster J, Winter J, Krauss S, Ropers HH, Schneider R, Schweiger S (2001) MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat Genet 29(3):287-294
59. Tsoupri Ε, Capetanaki Υ (2010) Study of the role of myospryn in heart, MSci thesis
60. Udd B, Vihola A, Sarparanta J, Richard I, Hackman P (2005) Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J. Neurobiology 64:636-642
61. van Spaendonck-Zwarts KY, van Hessem L, Jongbloed JD, de Walle HE, Capetanaki Y, van der Kooi AJ, van Langen IM, van den Berg MP, van Tintelen JP (2011) Desmin-related myopathy. Clin Genet 80:354-366
62. Walker MG (2001) Pharmaceutical target identification by gene expression analysis. Mini Rev Med Chem 1:197-205
63. Walsh MP, Busaan JL, Fraser ED, Fu SY, Pato MD, Michalak M (1995) Characterization of the recombinant C-terminal domain of dystrophin: phosphorylation by calmodulin-dependent protein kinase II and dephosphorylation by type 2B protein phosphatase. Biochemistry 34:5561-5568
64. Weisleder N, Taffet GE, Capetanaki Y (2004) Bcl-2 overexpression corrects mitochondrial defects and ameliorates inherited desmin null cardiomyopathy. Pro Natl Acad Sci USA 101:769-774
65. Weitzer G, Milner DJ, Kim JU, Bradley A, Capetanaki Y (1995) Cytoskeletal control of myogenesis: a desmin null mutation blocks the myogenic pathway during embryonic stem cell differentiation. Dev Biol 172:422-439
66. Witt CC, Burkart C, Labeit D, McNabb M, Wu Y, Granzier H, Labeit S (2006) Nebulin regulates thin filament length, contractility, and Z-disk structure in vivo. EMBO J 25(16):3843-3855